Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and female patients 18 to 65 years old (inclusive)
Patients with mild to moderate persistent asthma
BMI must be within the range of 18-32 kg/m2 inclusive
Female subjects must:
1. have been sterilized at least 6 months prior to screening
2. be post-menopausal with no regular bleeding for at least a year prior to inclusion
You may not be if
Patients with life-threatening arrhythmias
Patients with COPD or diabetes mellitus
History of immunocompromise, including a positive HIV
A positive Hepatitis B surface antigen (HBsAg) of Hepatitis C test result
Clareo Health | Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma
